A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.

Also called NCT04521023

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 132 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04521023
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04521023. Randomized; double masking; primary purpose treatment. Start 2017-09-20 (actual); primary completion 2020-01-28 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
Condition
Hypertension
Intervention (Drug)
Cantabell Tab
Intervention (Drug)
Candemore Plus Tab
Lead sponsor
Chong Kun Dang Pharmaceutical (class: industry)

Record details

Record id
cardio:ct-nct04521023
Content hash
c8e5e852bb1ce616392b190fc8a7c7a89974d3dec4dfbf8d5a71891600a20562